Cytomegalovirus Prophylaxis With Letermovir in Heart Transplant Recipients

Abroad (travel likely)RecruitingPHASE2

Conditions

CMV Viremia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University Medical Center Ljubljana, Ljubljana, Slovenia
Contact: Study coordinator (Bojan Vrtovec, MD, PhD) · mateja.lani@kclj.si · +38615221163
Gregor Poglajen, MD, PhD (Sub-investigator)

Study leads

Bojan Vrtovec, MD, PhD
Principal Investigator
Advanced Heart Failure and Transplantation Center, Universtiy Medical Center Ljubljana, Slovenia

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant

CMV Viremia · Heart Transplant Infection · Heart Transplant Failure and Rejection

Abroad (travel likely)RecruitingPHASE2, PHASE3

New York, United States · New York, United States

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Brain Cancer Metastatic · CMV Viremia

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Expansion of Virus-Specific Lymphocytes for Cell Therapy

CMV Viremia · CMV

Abroad (travel likely)RecruitingPHASE1

São Paulo, Brazil

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive · Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Atlanta, United States